A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene

Clinical trial NCT02141828 · COMPLETED

Trial details

NCT number: NCT02141828
Sponsor: Epizyme, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Acute Myeloid Leukemia Acute Lymphocytic Leukemia Acute Leukemias

Start date: 2014-05-01
Primary completion: 2016-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.